Supporting this, Sperber et al. showed that NMDAR-NR1 antibodies were associated with a high rate of stroke recurrence and, at higher titers, correlated with worse outcomes after cerebral ischemia (Sperber et al., 2019; Sperber et al., 2022). This evidence concerns the gene GRIN1 and brain ischemia.